Department of Global Health and Social Medicine, King's College London, London, United Kingdom.
Desmond Tutu Tuberculosis Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
JMIR Mhealth Uhealth. 2020 Nov 11;8(11):e19154. doi: 10.2196/19154.
Tuberculosis is the number one infectious cause of death globally. Young children, generally those younger than 5 years, are at the highest risk of progressing from tuberculosis infection to tuberculosis disease and of developing the most severe forms of tuberculosis. Most current tuberculosis drug formulations have poor acceptability among children and require consistent adherence for prolonged periods of time. These challenges complicate children's adherence to treatment and caregivers' daily administration of the drugs. Rapid developments in mobile technologies and apps present opportunities for using widely available technology to support national tuberculosis programs and patient treatment adherence. Pilot studies have demonstrated that mobile apps are a feasible and acceptable means of enhancing children's treatment adherence for other chronic conditions. Despite this, no mobile apps that aim to promote adherence to tuberculosis treatment have been developed for children. In this paper, we draw on our experiences carrying out research in clinical pediatric tuberculosis studies in South Africa. We present hypothetical scenarios of children's adherence to tuberculosis medication to suggest priorities for behavioral and educational strategies that a mobile app could incorporate to address some of the adherence support gaps faced by children diagnosed with tuberculosis. We argue that a mobile app has the potential to lessen some of the negative experiences that children associate with taking tuberculosis treatment and to facilitate a more positive treatment adherence experience for children and their caregivers.
结核病是全球头号传染病死因。幼儿(一般指 5 岁以下儿童)感染结核后发展为结核病、出现最严重结核病形式的风险最高。大多数现有的结核病药物配方在儿童中的接受度较差,需要长时间持续用药。这些挑战使得儿童难以坚持治疗,也使得照顾者难以每天为儿童用药。移动技术和应用程序的快速发展为利用广泛可用的技术支持国家结核病规划和患者治疗依从性提供了机会。试点研究表明,移动应用程序是增强儿童对其他慢性病治疗依从性的一种可行且可接受的方法。尽管如此,仍没有专门为儿童开发旨在促进结核病治疗依从性的移动应用程序。本文借鉴了我们在南非开展儿科结核病临床研究的经验。我们提出了儿童结核病药物治疗依从性的假设情景,以建议行为和教育策略的优先事项,移动应用程序可以纳入这些策略,以解决儿童结核病诊断后面临的一些依从性支持差距。我们认为,移动应用程序有可能减轻儿童与服用结核病治疗药物相关的一些负面体验,并为儿童及其照顾者提供更积极的治疗依从性体验。